StockData
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

GUIDED THERAPEUTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026

Market cap
$15.45M
P/E (TTM)
–
Dividend yield
–

About Guided Therapeutics

Electromedical & Electrotherapeutic Apparatus, SIC 3845

Guided Therapeutics, Inc. is a medical technology company focused on developing and commercializing medical devices for cancer detection. Its primary product is the LuViva Advanced Cervical Scan, a non-invasive, biophotonic point-of-care device designed to identify cervical cancers and precancers using light scanning, alongside single-use disposable calibration and alignment cervical guides. The company's technology serves two main applications: primary cervical cancer screening in developing regions and triage following abnormal Pap or HPV tests in developed markets. LuViva targets healthcare programs, foreign governments, non-governmental organizations, and clinical OB-GYN practices.

Operating primarily through regional and country-specific distributors, the company has executed formal distribution agreements covering over 40 countries, with active partnerships in regions including China, Southeast Asia, Central and Eastern Europe, and Russia. Through late 2025, it has distributed 158 LuViva devices and approximately 78,950 disposable cervical guides worldwide. Guided Therapeutics maintains three regular employees and is headquartered in Peachtree Corners, Georgia.

Summary of the business section of Guided Therapeutics's latest annual report, written by StockData.

Company profile

Company

Legal name
GUIDED THERAPEUTICS INC
Founded
1992
Headquarters
Peachtree Corners, GA
Address
5835 Peachtree Corners East, Suite B 30092
Phone
(770) 242-8723
Employees
3, Dec 31, 2025
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
UHY LLP, Sterling Heights, Michigan

Stock & identifiers

Ticker
GTHP
Exchange
OTC
IPO date
Jul 2, 1997
Shares outstanding
97M, Aug 7, 2026
Public float
$10.52M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-797 reverse, Nov 14, 2018; 1-for-812 reverse, Dec 5, 2016
SEC CIK
924515
EIN
58-2029543

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Richard P. BlumbergDirector13,543,130
Michael C. JamesDirector1,001,863
John E. ImhoffDirector21,252,673
Alan GrujicDirector1,817,541

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had three regular employees and five consultants to provide services to us on a full- or part-time basis.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 16, 2021Late filingNotification of late filing
May 17, 2021Late filingNotification of late filing
Mar 31, 2021Late filingNotification of late filing
Aug 17, 2020Late filingNotification of late filing
Jun 29, 2020Late filingNotification of late filing
Aug 15, 2019Late filingNotification of late filing
May 15, 2019Late filingNotification of late filing
Apr 1, 2019Late filingNotification of late filing
May 15, 2018Late filingNotification of late filing
Apr 2, 2018Late filingNotification of late filing
Nov 15, 2017Late filingNotification of late filing
Aug 15, 2017Late filingNotification of late filing
May 15, 2017Late filingNotification of late filing
Nov 15, 2016Late filingNotification of late filing
Aug 16, 2016Late filingNotification of late filing
May 17, 2016Late filingNotification of late filing
Aug 14, 2009Late filingNotification of late filing
Mar 31, 2009Late filingNotification of late filing
Nov 14, 2008Late filingNotification of late filing
Aug 13, 2008Late filingNotification of late filing
May 15, 2008Late filingNotification of late filing
Mar 31, 2008Late filingNotification of late filing
Feb 28, 2008Name changeName changed from SPECTRX INC to GUIDED THERAPEUTICS INC
Nov 14, 2007Late filingNotification of late filing
Nov 6, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 1, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
Aug 14, 2007Late filingNotification of late filing
May 15, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 15, 2007Late filingNotification of late filing
May 9, 2007Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)